Iranian Journal of Allergy, Asthma and Immunology, 2006 Previous studies have demonstrated some significant differences in HLA allele frequencies in leukemic patients and normal subjects. We have analyzed HLA class II alleles and haplotypes in 60 Iranian patients with acute myelogenous leukemia (AML) and 180
Abdolfattah Sarafnejad +7 more
doaj
Immunoreactive Calcitonin: A Tumor Marker for Myelogenous Leukemias
The International Journal of Biological Markers, 1990 In a series of 59 patients with chronic or acute myelogenous leukemia (CML, AML) we investigated whether circulating immunoreactive human calcitonin (i-hCT) levels correlate with diagnosis, response to therapy and clinical course. I-hCT was detectable in
P. Foa +6 more
doaj +1 more source
BMC Complementary and Alternative Medicine, 2012 Background In this report, the isorhamnetin 3-o-robinobioside and its original extract, the ethyl acetate extract, from Nitraria retusa leaves, were evaluated for their ability to induce antioxidant and antigenotoxic effects in human chronic myelogenous ...
Boubaker Jihed +4 more
doaj +1 more source
De novo appearance of the ph-1 chromosome in a previously monosomic bone marrow (45,XX,-6): conversion of a myeloproliferative disorder to acute myelogenous leukemia [PDF]
, 1975 G Kohn, N Manny, A Eldor, MM Cohen
openalex +1 more source
HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Leukemia
Iranian Journal of Allergy, Asthma and Immunology, 2007 Previous studies demonstrated significant differences in a number of HLA allele frequencies in leukemia patients and normal subjects. In this study, we have analyzed HLA class II alleles and haplotypes in 110 leukemia patients (60 acute myelogenous ...
Farideh Khosravi +7 more
doaj
Applications of Microarray Technology to Acute Myelogenous Leukemia
Cancer Informatics, 2009 Microarray technology is a powerful tool, which has been applied to further the understanding of gene expression changes in disease. Array technology has been applied to the diagnosis and prognosis of Acute Myelogenous Leukemia (AML).
Rashmi S. Goswami +4 more
doaj +1 more source
Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule [PDF]
, 1994 John C. Byrd, Raymond B. Weiss
openalex +1 more source
Supplementary Figure 2B from Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia [PDF]
, 2023 Marina Y. Konopleva +19 more
openalex +1 more source
Chronic myelogenous leukemia on target
Cancer Medicine, 2018 Chronic myelogenous leukemia (CML) is commonly treated with tyrosine kinase inhibitors (TKIs) that inhibit the pro‐leukemic activity of the BCR‐ABL1 oncoprotein.
Veronika Némethová, Filip Rázga
doaj +1 more source
Normal full‐term pregnancy in a patient with chronic myelogenous leukemia treated with α‐interferon [PDF]
, 1991 Maria R. Baer
openalex +1 more source